["{\n\"step_by_step_thinking\": \"The relevant documents describe the use of Foscarnet as an antiviral agent. One document mentions that Foscarnet is nephrotoxic, but it does not mention hyperkalemia or hypokalemia as adverse effects. Another document discusses laboratory abnormalities during Foscarnet therapy, including a decrease in serum calcium and phosphorus levels, which could suggest hypocalcemia. However, there is no mention of hypercalcemia.\",\n\"answer_choice\": \"B\""]